Andrew N Menzies-Gow

9PUBLICATIONS
87CO-AUTHORS
Disease surveillanceGene and molecular therapyNanotoxicology, health and safetyGene expression (incl. microarray and other genome-wide approaches)Toxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 29, 2025
Early and Sustained Asthma Control and Remission in Real-World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC-2.

Erika Penz, Thomas Rothe, Lieven Dupont

|May 30, 2025
Advancing Remission in Severe Asthma With Benralizumab: Latest Findings, Current Perspectives and Future Direction.

Renaud Louis, Marek Lommatzsch, David J Jackson

|Jul 05, 2022
Investigational approaches for unmet need in severe asthma.

David Watchorn, Andrew Menzies-Gow

|May 13, 2022
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes.

P Jane McDowell, John Busby, Catherine E Hanratty

|Oct 20, 2021
Oral corticosteroid stewardship for asthma: Time to move from theory to routine clinical practice.

David Watchorn, Andrew Menzies-Gow

Pageof 2